Search research articles
Contact Us
Filters
Showing results (421-430 of 520) with videos related to
Page
of 52
Sort By:
Nature
|
March 16, 2012
Suppression of the antiviral response by an influenza histone mimic
Ivan Marazzi, Jessica S Y Ho, Jaehoon Kim, et al.
Cell Reports. Medicine
|
July 26, 2021
Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity
Miriam Sindelar, Ethan Stancliffe, Michaela Schwaiger-Haber, et al.
Clinical and Vaccine Immunology : CVI
|
October 10, 2014
Immunologic characterization of a rhesus macaque H1N1 challenge model for candidate influenza virus vaccine assessment
Jason A Skinner, Sandra M Zurawski, Chie Sugimoto, et al.
Nature Communications
|
December 6, 2017
Pandemic H1N1 influenza A viruses suppress immunogenic RIPK3-driven dendritic cell death
Boris M Hartmann, Randy A Albrecht, Elena Zaslavsky, et al.
The Journal of Infectious Diseases
|
February 6, 2014
Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children
Raquel G Cao, Nicolas M Suarez, Gerlinde Obermoser, et al.
Annals of Surgery
|
June 15, 2006
Comparison between civilian burns and combat burns from Operation Iraqi Freedom and Operation Enduring Freedom
Steven E Wolf, David S Kauvar, Charles E Wade, et al.
Science Translational Medicine
|
March 15, 2013
Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination
Salah-Eddine Bentebibel, Santiago Lopez, Gerlinde Obermoser, et al.
Vaccines
|
December 22, 2020
A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine
Weina Sun, Stephen McCroskery, Wen-Chun Liu, et al.
Biorxiv : the Preprint Server for Biology
|
August 9, 2020
A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine
Weina Sun, Stephen McCroskery, Wen-Chun Liu, et al.
Nature
|
February 26, 2011
Programming the magnitude and persistence of antibody responses with innate immunity
Sudhir Pai Kasturi, Ioanna Skountzou, Randy A Albrecht, et al.
Page
of 52
Search research articles
Search
Showing results (421-430 of 520) with videos related to
Sort By:
Page
of 52
Nature
|
March 16, 2012
Suppression of the antiviral response by an influenza histone mimic
Ivan Marazzi, Jessica S Y Ho, Jaehoon Kim, et al.
Cell Reports. Medicine
|
July 26, 2021
Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity
Miriam Sindelar, Ethan Stancliffe, Michaela Schwaiger-Haber, et al.
Clinical and Vaccine Immunology : CVI
|
October 10, 2014
Immunologic characterization of a rhesus macaque H1N1 challenge model for candidate influenza virus vaccine assessment
Jason A Skinner, Sandra M Zurawski, Chie Sugimoto, et al.
Nature Communications
|
December 6, 2017
Pandemic H1N1 influenza A viruses suppress immunogenic RIPK3-driven dendritic cell death
Boris M Hartmann, Randy A Albrecht, Elena Zaslavsky, et al.
The Journal of Infectious Diseases
|
February 6, 2014
Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children
Raquel G Cao, Nicolas M Suarez, Gerlinde Obermoser, et al.
Annals of Surgery
|
June 15, 2006
Comparison between civilian burns and combat burns from Operation Iraqi Freedom and Operation Enduring Freedom
Steven E Wolf, David S Kauvar, Charles E Wade, et al.
Science Translational Medicine
|
March 15, 2013
Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination
Salah-Eddine Bentebibel, Santiago Lopez, Gerlinde Obermoser, et al.
Vaccines
|
December 22, 2020
A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine
Weina Sun, Stephen McCroskery, Wen-Chun Liu, et al.
Biorxiv : the Preprint Server for Biology
|
August 9, 2020
A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine
Weina Sun, Stephen McCroskery, Wen-Chun Liu, et al.
Nature
|
February 26, 2011
Programming the magnitude and persistence of antibody responses with innate immunity
Sudhir Pai Kasturi, Ioanna Skountzou, Randy A Albrecht, et al.
Page
of 52